HPMC supplementation reduces abdominal fat content, intestinal permeability, inflammation, and insulin resistance in diet-induced obese mice

Molecular Nutrition and Food Research

Volumn 56, Issue 9, 2012, Pages 1464-1476

  Kim, Hyunsook ^a,b   Bartley, Glenn E ^b   Young, Scott A ^c   Davis, Paul A ^a   Yokoyama, Wallace ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

^c DOW CHEMICAL COMPANY   (United States)

Author keywords

Adipogenesis; Inflammation; Insulin sensitivity; Intestinal permeability; Soluble dietary fiber

Indexed keywords

DRUG DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE;

ABDOMINAL FAT; ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; INTESTINE; LIPID DIET; LIPID METABOLISM; MALE; METABOLISM; MICROARRAY ANALYSIS; MOUSE; MOUSE MUTANT; OBESITY; PERMEABILITY; WEIGHT GAIN;

ABDOMINAL FAT; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; INTESTINES; LIPID METABOLISM; MALE; METHYLCELLULOSE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROARRAY ANALYSIS; OBESITY; PERMEABILITY; WEIGHT GAIN;

MUS;

EID: 84865762796     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200082     Document Type: Article

References (69)

1. Pickup, J. C., Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27, 813-823.
2. Brown, J., Wang, H., Hajishengallis, G. N., Martin, M., TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 2011, 90, 417-427.
3. Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, M. et al., Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E740-E747.
4. Nakarai, H., Yamashita, A., Nagayasu, S., Iwashita, M. et al., Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate Immun. 2012, 18, 164-170.
5. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A. et al., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G518-G525.
6. Neal, M. D., Leaphart, C., Levy, R., Prince, J. et al., Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 2006, 176, 3070-3079.
7. Dasu, M. R., Devaraj, S., Park, S., Jialal, I., Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33, 861-868.
8. Suzuki, T., Hara, H., Role of flavonoids in intestinal tight junction regulation. J. Nutr. Biochem. 2011, 22, 401-408.
9. Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
10. Chawla, A., Nguyen, K. D., Goh, Y. P., Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 2011, 11, 738-749.
11. Hoareau, L., Bencharif, K., Rondeau, P., Murumalla, R. et al., Signaling pathways involved in LPS induced TNFalpha production in human adipocytes. J. Inflamm. (Lond). 2010, 7, 1.
12. Qi L, van Dam, R. M., Liu, S., Franz, M. et al., Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 2006, 29, 207-211.
13. Ma, Y., Hebert, J. R., Li, W., Bertone-Johnson, E. R. et al., Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 2008, 24, 941-949.
14. Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y. et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58, 1091-1103.
15. Sanchez, D., Quinones, M., Moulay, L., Muguerza, B. et al., Soluble fiber-enriched diets improve inflammation and oxidative stress biomarkers in Zucker fatty rats. Pharmacol. Res. 2011, 64, 31-35.
16. Milagros, G., Manuel, S., Rocío, V., Mercedes, G., Anna, A. et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-α in obese Zucker rats. J. Nutr. 2005, 135, 2399-2404.
17. Sherry, C. L., Kim, S. S., Dilger, R. N., Bauer, L. L. et al., Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav. Immun. 2010, 24, 631-640.
18. Kallio, P., Kolehmainen, M., Laaksonen, D. E., Kekalainen, J. et al., Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am. J. Clin. Nutr. 2007, 85, 1417-1427.
19. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A. et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470-1481.
20. Maki, K. C., Carson, M. L., Kerr Anderson, W. H., Geohas, J. et al., Lipid-altering effects of different formulations of hydroxypropylmethylcellulose. J. Clin. Lipidol. 2009, 3, 159-166.
21. Maki, K. C., Davidson, M. H., Torri, S., Ingram, K. A. et al., High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men. J. Nutr. 2000, 130, 1705-1710.
22. Hung, S. C., Bartley, G., Young, S. A., Albers, D. R. et al., Dietary fiber improves lipid homeostasis and modulates adipocytokines in hamsters. J. Diabetes 2009, 1, 194-206.
23. Hung, S. C., Anderson, W. H., Albers, D. R., Langhorst, M. L. et al., Effect of hydroxypropyl methylcellulose on obesity and glucose metabolism in a diet-induced obesity mouse model. J. Diabetes 2011, 3, 158-167.
24. Kim, H., Bartley, G. E., Rimando, A. M., Yokoyama, W., Hepatic gene expression related to lower plasma cholesterol in hamsters fed high-fat diets supplemented with blueberry peels and peel extract. J. Agric. Food Chem. 2010, 58, 3984-3991.
25. Horton, J. D., Cuthbert, J. A., Spady, D. K., Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster. J. Clin. Invest. 1994, 93, 2084-2092.
26. German, J. B., Xu, R., Walzem, R., Kinsella, J.E. et al., Effect of dietary fats and barley fiber on total cholesterol and lipoprotein cholesterol distribution in plasma of hamsters. Nutr. Res. 1996, 16, 1239-1249.
27. Ortis, F., Naamane, N., Flamez, D., Ladriere, L. et al., Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells. Diabetes 2010, 59, 358-374.
28. Higami, Y., Barger, J. L., Page, G. P., Allison, D. B. et al., Energy restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the extracellular matrix, and angiogenesis in mouse adipose tissue. J. Nutr. 2006, 136, 343-352.
29. Cancello, R., Henegar, C., Viguerie, N., Taleb, S. et al., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54, 2277-2286.
30. Morton, N. M., Nelson, Y. B., Michailidou, Z., Di Rollo, E. M. et al., A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genes. PLoS One 2011, 6, e23944.
31. Koza, R. A., Nikonova, L., Hogan, J., Rim, J. S. et al., Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2006, 2, e81.
32. Tobias, P. S., Soldau, K., Ulevitch, R. J., Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 1989, 264, 10867-10871.
33. Battafaraono, R. J., Dahlberg, P. S., Ratz, C. A., Johnston, J. W. et al., Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery 1995, 118, 318-324.
34. Su, G. L., Freeswick, P. D., Geller, D. A., Wang, Q. et al., Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. Evidence for extrahepatic expression. J. Immunol. 1994, 153, 743-752.
35. Le, K. A., Mahurkar, S., Alderete, T. L., Hasson, R. E. et al., Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kappaB stress pathway. Diabetes 2011, 60, 2802-2809.
36. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S. et al., The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458, 1191-1195.
37. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I. et al., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116, 3015-3025.
38. He, G. Z., Zhou, K. G., Zhang, R., Chen, X. F., The effects of n-3 PUFA and intestinal lymph drainage on high-mobility group box 1 and Toll-like receptor 4 mRNA in rats with intestinal ischaemia-reperfusion injury. Br. J. Nutr. 2011, DOI: 10.1017/S0007114511006040.
39. Youn, J. H., Kwak, M. S., Wu, J., Kim, E. S. et al., Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. Eur. J. Immunol. 2011, 41, 2753-2762.
40. Kallio, K. A., Buhlin, K., Jauhiainen, M., Keva, R. et al., Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate. Immun. 2008, 14, 247-253.
41. Osto, M., Zini, E., Franchini, M., Wolfrum, C. et al., Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats. Endocrinology 2011, 152, 804-815.
42. Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A. et al., In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 1993, 90, 12040-12044.
43. Jiang, X. C., Bruce, C., Mar, J., Lin, M. et al., Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 1999, 103, 907-914.
44. Suzuki, T., Hara, H., Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr. Metab. (Lond). 2010, 7, 19.
45. Raimondi, F., Santoro, P., Barone, M. V., Pappacoda, S. et al., Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G906-G913.
46. Houdijk, A. P., Meijer, C., Cuesta, M. A., Meyer, S. et al., Perioperative anti-endotoxin strategies. Scand. J. Gastroenterol. Suppl. 1997, 222, 93-97.
47. Widberg, C. H., Newell, F. S., Bachmann, A. W., Ramnoruth, S. N. et al., Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E121-E131.
48. Yang, K., Guan, H., Arany, E., Hill, D. J. et al., Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J. 2008, 22, 2452-2464.
49. Catalioto, R. M., Maggi, C. A., Giuliani, S., Chemically distinct HDAC inhibitors prevent adipose conversion of subcutaneous human white preadipocytes at an early stage of the differentiation program. Exp. Cell. Res. 2009, 315, 3267-3280.
50. Swierczynski, J., Zabrocka, L., Goyke, E., Raczynska, S. et al., Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Mol. Cell. Biochem. 2003, 254, 55-59.
51. Gesta, S., Bluher, M., Yamamoto, Y., Norris, A. W. et al., Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. USA 2006, 103, 6676-6681.
52. Marshall, C. B., Krofft, R. D., Blonski, M. J., Kowalewska, J. et al., Role of smooth muscle protein SM22alpha in glomerular epithelial cell injury. Am. J. Physiol. Renal. Physiol. 2011, 300, F1026-F1042.
53. Cao, Y., Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 2007, 117, 2362-2368.
54. Pendas, A. M., Folgueras, A. R., Llano, E., Caterina, J. et al., Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol. Cell. Biol. 2004, 24, 5304-5313.
55. Moya, M. L., Lucas, S., Francis-Sedlak, M., Liu, X. et al., Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc. Res. 2009, 78, 142-147.
56. Ivanciu, L., Gerard, R. D., Tang, H., Lupu, F. et al., Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 310-316.
57. Christianson, J. L., Nicoloro, S., Straubhaar, J., Czech, M. P., Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells. J. Biol. Chem. 2008, 283, 2906-2916.
58. Warne, J. P., John, C. D., Christian, H. C., Morris, J. F. et al., Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2006, 291, E1264-E1273.
59. Cao, Y., Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov. 2010, 9, 107-115.
60. Xue, Y., Petrovic, N., Cao, R., Larsson, O. et al., Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 2009, 9, 99-109.
61. Trayhurn, P., Wood, I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92, 347-355.
62. Pang, C., Gao, Z., Yin, J., Zhang, J. et al., Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E313-E322.
63. Miranda, M., Chacon, M. R., Gutierrez, C., Vilarrasa, N. et al., LMNA mRNA expression is altered in human obesity and type 2 diabetes. Obesity (Silver Spring) 2008, 16, 1742-1748.
64. Pihlajamaki, J., Lerin, C., Itkonen, P., Boes, T. et al., Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab. 2011, 14, 208-218.
65. Salati, L. M., Szeszel-Fedorowicz, W., Tao, H., Gibson, M. A. et al., Nutritional regulation of mRNA processing. J. Nutr. 2004, 134, 2437S-2443S.
66. Sakla, M. S., Lorson, C. L., Induction of full-length survival motor neuron by polyphenol botanical compounds. Hum. Genet. 2008, 122, 635-643.
67. Fernandez, C. M., Molto, E., Gallardo, N., Del Arco, A. et al., The expression of rat resistin isoforms is differentially regulated in visceral adipose tissues: effects of aging and food restriction. Metabolism 2009, 58, 204-211.
68. Lin, J. C., Tarn, W. Y., RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. J. Cell Biol. 2011, 193, 509-520.
69. Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J. et al., Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007, 30, 753-759.